Reported about 1 month ago
CVS Health's CEO Karen Lynch is set to be replaced by David Joyner due to ongoing profit issues, causing the company's stock to drop over 6% in pre-market trading. As CVS shares adjust, the company is also retracting its profit forecasts for 2024, with third-quarter results expected to be announced on November 6.
Source: YAHOO